These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16633327)

  • 1. The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cells.
    Seeger H; Mueck AO
    Panminerva Med; 2006 Mar; 48(1):13-7. PubMed ID: 16633327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors?
    Seeger H; Wallwiener D; Mueck AO
    Eur J Gynaecol Oncol; 2006; 27(2):139-41. PubMed ID: 16620055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].
    Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pharmacological concentrations of estrogens on growth of 3AO human ovarian cancer cells.
    Li ZB; Chen YX; Zhao JY; Lu J
    Yi Chuan Xue Bao; 2006 Sep; 33(9):782-92. PubMed ID: 16980124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.
    Seeger H; Deuringer FU; Wallwiener D; Mueck AO
    Maturitas; 2004 Nov; 49(3):235-40. PubMed ID: 15488352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Eur J Gynaecol Oncol; 2005; 26(4):383-5. PubMed ID: 16122183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
    Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different progestogens on human breast tumor cell growth.
    Chen FP; Chien MH; Chen HY; Ng YT
    Climacteric; 2011 Jun; 14(3):345-51. PubMed ID: 21375453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen plays a critical role in AAV2-mediated gene transfer in ovarian cancer.
    Shi WF; Bartlett JS
    Acta Pharmacol Sin; 2008 Dec; 29(12):1440-50. PubMed ID: 19026163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular effects of gestagens--biochemistry versus epidemiology].
    Kuhl H
    Zentralbl Gynakol; 1999; 121(2):67-78. PubMed ID: 10096172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
    Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of estrogens and progestogens: influence of different routes of administration.
    Kuhl H
    Climacteric; 2005 Aug; 8 Suppl 1():3-63. PubMed ID: 16112947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.